FDA inspection
Chartwell Pharmaceuticals Amityville, LLC: FDA inspection ending Dec 21, 2022
FDA inspection 1193806 · Voluntary Action Indicated (VAI) · Amityville, NY
Key facts
| Inspection ID | 1193806 |
|---|---|
| Firm | Chartwell Pharmaceuticals Amityville, LLC |
| FEI number | 2433247 |
| Address | 219 Dixon Ave |
| City | Amityville |
| State | NY |
| ZIP | 11701 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Dec 21, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data